Article Text

Unusual presentation of more common disease/injury
Rapid development of a hepatocellular carcinoma in isolated thrombosis of hepatic veins (classic Budd–Chiari syndrome): case report and review of literature
  1. Jens Walldorf1,
  2. Andrea Tannapfel2,
  3. Hans Jürgen Holzhausen3,
  4. Christian Wittekind4,
  5. Thomas Seufferlein1,
  6. Utz Settmacher5,
  7. Wolfgang E Fleig6,
  8. Matthias M Dollinger1
  1. 1
    University of Halle-Wittenberg, Department of Internal Medicine I, Ernst-Grube-Strasse 20, Halle, 06120, Germany
  2. 2
    Berufsgenossenschaftliche Universitätsklinik Bergmannsheil, Institute of Pathology, Bürkle-de-la-Camp-Platz 1, Bochum, 44789, Germany
  3. 3
    University of Halle-Wittenberg, Institute for Pathology, Magdeburger Str. 14, Halle, 06112, Germany
  4. 4
    University of Leipzig, Institute for Pathology, Liebigstrasse 26, Leipzig, 04103, Germany
  5. 5
    Friedrich-Schiller-University, Department of General and Visceral Surgery, Erlanger Allee 101, Jena, 07747, Germany
  6. 6
    University of Leipzig Hospitals and Clinics, Philipp-Rosenthal-Str. 27, Leipzig, 04103, Germany
  1. Matthias M Dollinger, matthias.dollinger{at}medizin.uni-halle.de

Summary

Budd–Chiari syndrome and membranous obstruction of the inferior vena cava frequently result in the development of mostly benign hepatic lesions. In cases of membranous obstruction of the inferior vena cava, which is prevalent mostly in the East, these lesions often progress to hepatocellular carcinoma. In contrast, malignant transformation has not yet been recognised in patients with isolated hepatic vein thrombosis. We report the case of a 37-year-old male Caucasian who presented with acute Budd–Chiari syndrome without involvement of the inferior vena cava. Despite porto-caval shunting, a hepatocellular carcinoma developed within several months. Three hepatic lesions were treated by radiofrequency thermal ablation until liver transplantation was performed. This report emphasises the possibility of malignant transformation of regenerative nodules in patients with disturbed hepatic perfusion in general. Physicians must be aware of this when assessing regenerative nodules, especially as no unambiguous predictors for the development of hepatocellular carcinoma have been identified so far.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Competing interests: none.

  • Patient consent: Patient/guardian consent was obtained for publication